Related Experiment Videos
Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA
H J Lin1, L E Myers, B Yen-Lieberman
1Division of Molecular Virology, Baylor College of Medicine, Houston, Texas.
The Journal of Infectious Diseases
|September 1, 1994
Summary
Quantitative human immunodeficiency virus type 1 (HIV-1) RNA assays are reliable for clinical trials. Several methods accurately measure HIV-1 RNA levels, showing reproducibility and sensitivity for patient monitoring.
Area of Science:
- Virology
- Immunology
- Clinical Diagnostics
Background:
- Accurate quantification of human immunodeficiency virus type 1 (HIV-1) RNA is crucial for monitoring disease progression and treatment efficacy.
- Existing methods for HIV-1 RNA quantification varied in sample volume, preparation, amplification, and detection techniques.
Purpose of the Study:
- To evaluate and compare the performance of six different procedures for quantifying plasma HIV-1 RNA.
- To assess the reproducibility and sensitivity of these assays for use in clinical settings.
Main Methods:
- Nine laboratories evaluated six distinct HIV-1 RNA quantification procedures.
- Coded samples, including a 10-fold dilution series of spiked plasma and patient samples, were tested.
- Assays were compared based on sample volume, preparation, amplification, and detection methods.
Main Results:
- All six procedures correctly ranked HIV-1 RNA levels in dilution series.
- Several procedures demonstrated sufficient reproducibility, with a 4-fold change considered significant.
- HIV-1 RNA levels correlated with proviral DNA and inversely with CD4 cell counts.
- HIV-1 RNA assays showed higher sensitivity than plasma viremia and p24 antigen assays.
Conclusions:
- Multiple quantitative HIV-1 RNA assays are sufficiently reproducible and sensitive for clinical use.
- These validated assays are ready for implementation in clinical trials for HIV-1 management.
- Quantitative HIV-1 RNA measurement provides valuable insights into disease status and treatment response.